by Truveta staff | Oct 26, 2023 | Data
Hidden under the surface of daily life, a disease often referred to as a “silent killer” is slowly taking hold over millions of Americans. While approximately 4.5M US adults have received a diagnosis of liver disease, a far larger yet largely unaware group is treading...
by Truveta staff | Oct 24, 2023 | Research
Each year, approximately 900,000 patients in the United States are affected by PE, a blood clot causing a blockage in one or more pulmonary arteries in the lungs and a leading cause of in-hospital death in the U.S. Acute pulmonary embolism (PE) is the third-leading...
by Truveta News | Oct 23, 2023 | News
Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical centers, and research institutes to study safety and effectiveness, improve patient care and train medical AI. Truveta welcomes...
by Truveta Research | Oct 17, 2023 | Research, Research Insights
Social drivers of health (SDOH), such as increased financial struggles and decreased social support, have been shown to be correlated with decreased medication adherence. In this study, we saw an increased rate of medication adherence for those with individual incomes...
by Truveta staff | Oct 11, 2023 | News
Truveta today announced it has completed a Type 2 System and Organization Controls (SOC) 2 examination, which underscores Truveta’s commitments to security and trust. Type 2 SOC 2 is a rigorous and comprehensive compliance standard developed and governed by the...
by Truveta staff | Oct 10, 2023 | Research, Research Insights
The aim of this analysis was to compare different prescription trends post-venous stenting and set the foundation for future research. We identified a disparity showing that certain populations are less likely to receive prescriptions for medications within 30 days...
by Truveta Research | Oct 5, 2023 | Research, Research Insights
Annually, over 125,000 deaths are associated with poor medication adherence. The proportion of days covered (PDC) is a common method to measure adherence. When controlling for age, sex, race, and ethnicity, we found similar rates of first year medication adherence for...
by Truveta staff | Oct 2, 2023 | Data
In the realm of medtech innovation, the margin for error is slim. Upwards of 90% of funding for an early-stage company may be allocated to engineering and clinical costs, making it essential for leaders to de-risk their clinical programs. Having access to a...
by Truveta staff | Sep 29, 2023 | News
LinkedIn’s 7th annual Top Startups list – a ranking based on LinkedIn data of the top 50 emerging US companies – has some fresh new faces on it, including Truveta. The list is based on four key criteria: Employee growth Jobseeker interest Member engagement within...
by Truveta staff | Sep 28, 2023 | Technology
It’s only September, but COVID-19 and respiratory syncytial virus (RSV) cases are already rising. The latest Truveta Research monitoring report shows that for people over 65, COVID continues to be the most prevalent respiratory virus associated with hospitalizations....
